Home » Investing

Image for UiPath (NYSE:PATH) PT Raised to $30.00

UiPath (NYSE:PATH) PT Raised to $30.00

UiPath (NYSE:PATH – Get Free Report) had its price objective raised by equities research analysts at Scotiabank from $29.00 to $30.00 in a report issued on Thursday, Benzinga reports. The firm currently has a “sector perform”... More of this article »
Image for UiPath (NYSE:PATH) Price Target Increased to $30.00 by Analysts at Canaccord Genuity Group

UiPath (NYSE:PATH) Price Target Increased to $30.00 by Analysts at Canaccord Genuity Group

UiPath (NYSE:PATH – Free Report) had its target price hoisted by Canaccord Genuity Group from $27.00 to $30.00 in a research note released on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating... More of this article »
Image for UiPath (NYSE:PATH) Price Target Raised to $24.00 at DA Davidson

UiPath (NYSE:PATH) Price Target Raised to $24.00 at DA Davidson

UiPath (NYSE:PATH – Free Report) had its price target raised by DA Davidson from $20.00 to $24.00 in a research report sent to investors on Thursday, Benzinga reports. DA Davidson currently has a neutral rating on the healthcare... More of this article »
Image for Phreesia (NYSE:PHR) Stock Rating Reaffirmed by JMP Securities

Phreesia (NYSE:PHR) Stock Rating Reaffirmed by JMP Securities

JMP Securities reaffirmed their market outperform rating on shares of Phreesia (NYSE:PHR – Free Report) in a research report report published on Friday morning, Benzinga reports. They currently have a $28.00 target price on... More of this article »
Image for Phreesia (NYSE:PHR) Price Target Increased to $23.00 by Analysts at Royal Bank of Canada

Phreesia (NYSE:PHR) Price Target Increased to $23.00 by Analysts at Royal Bank of Canada

Phreesia (NYSE:PHR – Free Report) had its target price increased by Royal Bank of Canada from $17.00 to $23.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a sector perform rating... More of this article »
Image for Bond & Devick Financial Network Inc. Purchases 54 Shares of Adobe Inc. (NASDAQ:ADBE)

Bond & Devick Financial Network Inc. Purchases 54 Shares of Adobe Inc. (NASDAQ:ADBE)

Bond & Devick Financial Network Inc. increased its position in shares of Adobe Inc. (NASDAQ:ADBE – Free Report) by 9.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.... More of this article »
Image for Wedbush Raises DICK’S Sporting Goods (NYSE:DKS) Price Target to $210.00

Wedbush Raises DICK’S Sporting Goods (NYSE:DKS) Price Target to $210.00

DICK’S Sporting Goods (NYSE:DKS – Free Report) had its price objective lifted by Wedbush from $160.00 to $210.00 in a research report sent to investors on Friday morning, Benzinga reports. Wedbush currently has a neutral... More of this article »
Image for Wells Fargo & Company Boosts DICK’S Sporting Goods (NYSE:DKS) Price Target to $210.00

Wells Fargo & Company Boosts DICK’S Sporting Goods (NYSE:DKS) Price Target to $210.00

DICK’S Sporting Goods (NYSE:DKS – Free Report) had its price objective increased by Wells Fargo & Company from $175.00 to $210.00 in a research report report published on Friday, Benzinga reports. The brokerage currently... More of this article »
Image for Canaccord Genuity Group Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $377.00

Canaccord Genuity Group Raises Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $377.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) had its target price lifted by Canaccord Genuity Group from $338.00 to $377.00 in a research report released on Friday morning, Benzinga reports. They currently have a buy... More of this article »
Image for FedEx Co. (NYSE:FDX) Sees Large Drop in Short Interest

FedEx Co. (NYSE:FDX) Sees Large Drop in Short Interest

FedEx Co. (NYSE:FDX – Get Free Report) was the recipient of a significant decrease in short interest in the month of February. As of February 29th, there was short interest totalling 3,170,000 shares, a decrease of 14.6% from... More of this article »
Image for Summit Materials (NYSE:SUM) Price Target Raised to $50.00

Summit Materials (NYSE:SUM) Price Target Raised to $50.00

Summit Materials (NYSE:SUM – Free Report) had its price target lifted by Truist Financial from $46.00 to $50.00 in a research report sent to investors on Friday, Benzinga reports. They currently have a buy rating on the construction... More of this article »
Image for Costco Wholesale (NASDAQ:COST) PT Raised to $870.00 at Tigress Financial

Costco Wholesale (NASDAQ:COST) PT Raised to $870.00 at Tigress Financial

Costco Wholesale (NASDAQ:COST – Get Free Report) had its price objective hoisted by stock analysts at Tigress Financial from $745.00 to $870.00 in a research note issued on Friday, Benzinga reports. The firm currently has a... More of this article »
Image for Keefe, Bruyette & Woods Lowers Oportun Financial (NASDAQ:OPRT) Price Target to $4.00

Keefe, Bruyette & Woods Lowers Oportun Financial (NASDAQ:OPRT) Price Target to $4.00

Oportun Financial (NASDAQ:OPRT – Free Report) had its target price reduced by Keefe, Bruyette & Woods from $4.50 to $4.00 in a report released on Thursday, Benzinga reports. They currently have a market perform rating on... More of this article »
Image for DICK’S Sporting Goods (NYSE:DKS) PT Raised to $226.00 at TD Cowen

DICK’S Sporting Goods (NYSE:DKS) PT Raised to $226.00 at TD Cowen

DICK’S Sporting Goods (NYSE:DKS – Free Report) had its price target upped by TD Cowen from $177.00 to $226.00 in a report published on Thursday, Benzinga reports. The firm currently has an outperform rating on the sporting... More of this article »
Image for Mizuho Increases Magnolia Oil & Gas (NYSE:MGY) Price Target to $26.00

Mizuho Increases Magnolia Oil & Gas (NYSE:MGY) Price Target to $26.00

Magnolia Oil & Gas (NYSE:MGY – Free Report) had its price target boosted by Mizuho from $24.00 to $26.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a neutral rating on the stock. Several... More of this article »
Image for MeiraGTx’s (MGTX) “Outperform” Rating Reiterated at Royal Bank of Canada

MeiraGTx’s (MGTX) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of MeiraGTx (NASDAQ:MGTX – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $11.00 price objective on the stock. MeiraGTx... More of this article »
Image for Lincoln Capital LLC Purchases New Stake in International Business Machines Co. (NYSE:IBM)

Lincoln Capital LLC Purchases New Stake in International Business Machines Co. (NYSE:IBM)

Lincoln Capital LLC purchased a new stake in International Business Machines Co. (NYSE:IBM – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Image for Chardan Capital Increases Silence Therapeutics (NASDAQ:SLN) Price Target to $42.00

Chardan Capital Increases Silence Therapeutics (NASDAQ:SLN) Price Target to $42.00

Silence Therapeutics (NASDAQ:SLN – Get Free Report) had its target price increased by analysts at Chardan Capital from $26.00 to $42.00 in a report released on Thursday, Benzinga reports. The firm presently has a “buy”... More of this article »
Image for Mattel (NASDAQ:MAT) Price Target Increased to $20.00 by Analysts at Jefferies Financial Group

Mattel (NASDAQ:MAT) Price Target Increased to $20.00 by Analysts at Jefferies Financial Group

Mattel (NASDAQ:MAT – Free Report) had its target price hoisted by Jefferies Financial Group from $19.00 to $20.00 in a research report report published on Friday, Benzinga reports. They currently have a hold rating on the stock. A... More of this article »
Image for Summit Materials (NYSE:SUM) Price Target Increased to $45.00 by Analysts at Barclays

Summit Materials (NYSE:SUM) Price Target Increased to $45.00 by Analysts at Barclays

Summit Materials (NYSE:SUM – Free Report) had its price target boosted by Barclays from $40.00 to $45.00 in a research note released on Thursday, Benzinga reports. Barclays currently has an equal weight rating on the construction... More of this article »
Image for Aurora Innovation (NASDAQ:AUR) Price Target Raised to $6.00

Aurora Innovation (NASDAQ:AUR) Price Target Raised to $6.00

Aurora Innovation (NASDAQ:AUR – Free Report) had its price objective hoisted by Canaccord Genuity Group from $5.50 to $6.00 in a report issued on Friday morning, Benzinga reports. They currently have a buy rating on the stock. Several... More of this article »
Image for TD Cowen Cuts Aurora Innovation (NASDAQ:AUR) Price Target to $3.00

TD Cowen Cuts Aurora Innovation (NASDAQ:AUR) Price Target to $3.00

Aurora Innovation (NASDAQ:AUR – Free Report) had its price objective trimmed by TD Cowen from $3.50 to $3.00 in a research report report published on Friday morning, Benzinga reports. The firm currently has a market perform rating... More of this article »
Image for Aurora Innovation (NASDAQ:AUR) Price Target Cut to $3.00

Aurora Innovation (NASDAQ:AUR) Price Target Cut to $3.00

Aurora Innovation (NASDAQ:AUR – Get Free Report) had its price objective decreased by research analysts at TD Cowen from $3.50 to $3.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “market... More of this article »
Image for Scotiabank Increases UiPath (NYSE:PATH) Price Target to $30.00

Scotiabank Increases UiPath (NYSE:PATH) Price Target to $30.00

UiPath (NYSE:PATH – Free Report) had its price target increased by Scotiabank from $29.00 to $30.00 in a research report released on Thursday morning, Benzinga reports. The firm currently has a sector perform rating on the healthcare... More of this article »
Image for UiPath (NYSE:PATH) Given New $27.00 Price Target at Evercore ISI

UiPath (NYSE:PATH) Given New $27.00 Price Target at Evercore ISI

UiPath (NYSE:PATH – Free Report) had its price target boosted by Evercore ISI from $24.00 to $27.00 in a report issued on Thursday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the healthcare company’s... More of this article »
Image for UiPath (NYSE:PATH) Price Target Increased to $25.00 by Analysts at Wells Fargo & Company

UiPath (NYSE:PATH) Price Target Increased to $25.00 by Analysts at Wells Fargo & Company

UiPath (NYSE:PATH – Free Report) had its price target raised by Wells Fargo & Company from $24.00 to $25.00 in a report issued on Thursday, Benzinga reports. The firm currently has an equal weight rating on the healthcare... More of this article »
Image for UiPath (NYSE:PATH) Given New $28.00 Price Target at BMO Capital Markets

UiPath (NYSE:PATH) Given New $28.00 Price Target at BMO Capital Markets

UiPath (NYSE:PATH – Free Report) had its target price boosted by BMO Capital Markets from $24.00 to $28.00 in a report published on Thursday, Benzinga reports. They currently have a market perform rating on the healthcare company’s... More of this article »
Image for UiPath (NYSE:PATH) Given New $25.00 Price Target at Morgan Stanley

UiPath (NYSE:PATH) Given New $25.00 Price Target at Morgan Stanley

UiPath (NYSE:PATH – Free Report) had its target price upped by Morgan Stanley from $17.00 to $25.00 in a research note released on Thursday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the... More of this article »
Image for Kesler Norman & Wride LLC Reduces Stock Position in Costco Wholesale Co. (NASDAQ:COST)

Kesler Norman & Wride LLC Reduces Stock Position in Costco Wholesale Co. (NASDAQ:COST)

Kesler Norman & Wride LLC lessened its stake in Costco Wholesale Co. (NASDAQ:COST – Free Report) by 5.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.... More of this article »
Image for Microsoft (NASDAQ:MSFT) Earns Buy Rating from DA Davidson

Microsoft (NASDAQ:MSFT) Earns Buy Rating from DA Davidson

DA Davidson restated their buy rating on shares of Microsoft (NASDAQ:MSFT – Free Report) in a report published on Friday, Benzinga reports. They currently have a $500.00 target price on the software giant’s stock. Several... More of this article »
Image for Phathom Pharmaceuticals (NASDAQ:PHAT) Given “Buy” Rating at Needham & Company LLC

Phathom Pharmaceuticals (NASDAQ:PHAT) Given “Buy” Rating at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research report report published on Friday morning, Benzinga reports. Needham & Company LLC currently... More of this article »
Image for Northland Securities Trims Mondee (NASDAQ:MOND) Target Price to $4.50

Northland Securities Trims Mondee (NASDAQ:MOND) Target Price to $4.50

Mondee (NASDAQ:MOND – Free Report) had its price target cut by Northland Securities from $6.50 to $4.50 in a report published on Friday, Benzinga reports. They currently have an outperform rating on the stock. Separately, Morgan... More of this article »
Image for Jefferies Financial Group Increases Mattel (NASDAQ:MAT) Price Target to $20.00

Jefferies Financial Group Increases Mattel (NASDAQ:MAT) Price Target to $20.00

Mattel (NASDAQ:MAT – Get Free Report) had its target price upped by equities research analysts at Jefferies Financial Group from $19.00 to $20.00 in a research note issued on Friday, Benzinga reports. The brokerage presently... More of this article »
Image for Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $377.00

Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Raised to $377.00

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) had its price objective boosted by investment analysts at Canaccord Genuity Group from $338.00 to $377.00 in a research report issued to clients and investors on Friday,... More of this article »
Image for Spruce Biosciences (NASDAQ:SPRB) PT Lowered to $3.00 at JMP Securities

Spruce Biosciences (NASDAQ:SPRB) PT Lowered to $3.00 at JMP Securities

Spruce Biosciences (NASDAQ:SPRB – Free Report) had its price objective trimmed by JMP Securities from $8.00 to $3.00 in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a market outperform... More of this article »
Image for ESS Tech (NYSE:GWH) PT Lowered to $1.25 at Canaccord Genuity Group

ESS Tech (NYSE:GWH) PT Lowered to $1.25 at Canaccord Genuity Group

ESS Tech (NYSE:GWH – Free Report) had its price target reduced by Canaccord Genuity Group from $1.75 to $1.25 in a research note issued to investors on Thursday, Benzinga reports. They currently have a hold rating on the stock. Several... More of this article »
Image for Silence Therapeutics (NASDAQ:SLN) PT Raised to $42.00

Silence Therapeutics (NASDAQ:SLN) PT Raised to $42.00

Silence Therapeutics (NASDAQ:SLN – Free Report) had its price objective boosted by Chardan Capital from $26.00 to $42.00 in a report published on Thursday, Benzinga reports. The firm currently has a buy rating on the stock. A... More of this article »
Image for Oppenheimer Reaffirms Market Perform Rating for Lennar (NYSE:LEN)

Oppenheimer Reaffirms Market Perform Rating for Lennar (NYSE:LEN)

Oppenheimer reaffirmed their market perform rating on shares of Lennar (NYSE:LEN – Free Report) in a research report report published on Friday, Benzinga reports. Several other equities analysts also recently issued reports... More of this article »
Image for SentinelOne (NYSE:S) PT Raised to $37.00

SentinelOne (NYSE:S) PT Raised to $37.00

SentinelOne (NYSE:S – Free Report) had its price target raised by Sanford C. Bernstein from $34.00 to $37.00 in a report issued on Thursday, Benzinga reports. They currently have an outperform rating on the stock. S has been... More of this article »
Image for ESS Tech (NYSE:GWH) Given New $0.80 Price Target at Chardan Capital

ESS Tech (NYSE:GWH) Given New $0.80 Price Target at Chardan Capital

ESS Tech (NYSE:GWH – Free Report) had its price objective reduced by Chardan Capital from $1.90 to $0.80 in a research note issued to investors on Friday morning, Benzinga reports. They currently have a neutral rating on the... More of this article »